SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharmaceuticals reports consolidated net profit of Rs 111 crore in Q4

31 May 2013 Evaluate

Torrent Pharmaceuticals has reported results for quarter and year ended March 31, 2013.

The company’s net profit has surged by 91.25% at Rs 153 crore for Q4FY13 as compared to Rs 80 crore in Q4FY12. Its total income from operations increased by 41.28% to Rs 770 crore in the quarter under review from Rs 545 crore  in the corresponding quarter of the previous year.

On consolidated basis, company reported a net profit of Rs 111 crore for Q4FY13 as compared to a net loss of Rs 1 crore in Q4FY12. Its total income from operations increased by 29.23% at Rs 871 crore  in the quarter under review from Rs 674 crore in the corresponding quarter of the previous year.

For the full year ended March 31, 2013, the company’s net profit jumped higher by 75.56% at Rs 546 crore as against Rs 311 crore in the FY 12. Its total income from operations surged 33.29% at Rs 2767 crore from the quarter under review as compared to Rs 2076 crore in corresponding quarter of the previous year.

On consolidated basis, the full year ended March 31, 2013, the group’s net profit grew by 52.09% at Rs 435 crore as against Rs 286 crore in the FY12. Its total income from operations rose by 19.14% at Rs 3212 crore from the year as compared to Rs 2696 crore in previous fiscal.

Torrent Pharma Share Price

4145.75 65.05 (1.59%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×